Tuesday, May 8, 2012

Partnerships Latin America Session Spotlight: Global Trend Spotlight: A Look at Clinical Trial Investments and Outsourcing Dollars Around the World

As we gear up for Partnerships in Clinical Trials Latin America, we'll feature of one of the sessions from the upcoming conference.  Partnerships in Clinical Trials Latin America will take place August 13-15, 2012 in Sao Paulo, Brazil.  Next, we're taking a look at the keynote from John Kregar, which will focus the changing landscape of the clinical trial outsourcing industry.  For more information on Dr. Kasher's session and the rest of the program, download the brochure today.  Also, when you register to join us in Brazil and mention code XP1718BLOG to save $100 off the current rate.

Featured Session: Global Trend Spotlight: A Look at Clinical Trial Investments and Outsourcing Dollars Around the World

Featured Speaker: John Kregar, Principal, Healthcare Equity Research, Analyst, William Blair & Company

About the session:
The accelerating pace of health care innovation–among a confluence of other factors–is dramatically changing everything from the way drugs, devices, diagnostics are discovered and developed to how they are delivered and paid for. This session provides a comprehensive overview of the evolving clinical trial outsourcing landscape with a particular eye toward sourcing issues and financial considerations.
  • • Examine the implications of the global trend of large pharma and preferred providers on local vendors, local players, large pharma in Latam
  • • Assess the impact of M&A from CRO and Pharma side onclinical trials market in LATAM
  • • Identify investment areas and growth opportunities for countries in LATAM
  • • Hear Wall Street’s take on the clinical outsourcing market
  • • Learn best practices in strategic clinical outsourcing contracting
  • • Explore clinical research outsourcing considerations from a major pharma perspective
  • • Review trends in global sourcing and spending
  • • Examine case studies to help guide strategic decision making from a practical, fiscally responsible point of view

No comments: